SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-267364
Filing Date
2021-09-08
Accepted
2021-09-08 08:42:55
Documents
14
Period of Report
2021-09-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d196078d8k.htm   iXBRL 8-K 30311
2 EX-10.1 d196078dex101.htm EX-10.1 81854
3 EX-99.1 d196078dex991.htm EX-99.1 11391
  Complete submission text file 0001193125-21-267364.txt   278251

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA nerv-20210902.xsd EX-101.SCH 2914
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE nerv-20210902_lab.xml EX-101.LAB 18906
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nerv-20210902_pre.xml EX-101.PRE 11877
7 EXTRACTED XBRL INSTANCE DOCUMENT d196078d8k_htm.xml XML 3474
Mailing Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451 617-600-7373
Minerva Neurosciences, Inc. (Filer) CIK: 0001598646 (see all company filings)

IRS No.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36517 | Film No.: 211240818
SIC: 2834 Pharmaceutical Preparations